Jorgen Wittendorff
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Jorgen Wittendorff
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
16
| Subsidiary | Biotechnology | 16 |
| Public Company | Miscellaneous Commercial Services | 11 | |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jorgen Wittendorff
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| The University of Chicago | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| ARATANA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
| The University of Sheffield | College/University | Doctorate Degree Undergraduate Degree | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman Chief Executive Officer | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director of Finance/CFO General Counsel | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Utrecht | College/University | Graduate Degree Undergraduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of Antwerp | College/University | Graduate Degree Graduate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SEQUANA MEDICAL N.V. | Medical Specialties | Director/Board Member Investor Relations Contact | |
| BIOTALYS NV | Chemicals: Agricultural | Director of Finance/CFO Director/Board Member | |
| ABIONYX PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| SEVER Life Sciences BV | Chairman Director/Board Member | ||
| The University of Texas at Austin | College/University | Doctorate Degree Doctorate Degree | |
| Janssen Biotherapeutics | Corporate Officer/Principal Corporate Officer/Principal | ||
| PHARNEXT SCA | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| BIOCARTIS GROUP NV | Medical Specialties | Chief Executive Officer Chief Operating Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ionix Pharmaceuticals Ltd.
 Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ionix Pharmaceuticals Ltd. used to develop analgesic medicines for the treatment of acute and chronic pain. Its drugs were used for the treatment of pain associated with chronic debilitating diseases such as osteoarthritis, diabetes, cancer and multiple sclerosis. The company was founded by Andrew Sandham, Phillip J. Birch, John Wood and Ann Gail Hayes in 2001 and was located in Cambridge, UK. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Chief Executive Officer | |
| Midwest Lipid Association | Director/Board Member | ||
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Medical/Nursing Services | Corporate Officer/Principal | |
American College of Chest Physicians
 American College of Chest Physicians Miscellaneous Commercial ServicesCommercial Services The American College of Chest Physicians is a leading organization in clinical chest medicine, with over 19,000 members providing patient care in pulmonary, critical care, and sleep medicine in more than 100 countries worldwide. The non-profit company is based in Northbrook, IL. The organization offers access to clinical guidelines, new research, and clinical topic collections through their website, as well as opportunities for members to become more involved in the chest medicine community. The organization's mission is to promote the prevention, diagnosis, and treatment of chest diseases through education, communication, and research. Robert A. Musacchio has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Chicago Center for Clinical Research
 Chicago Center for Clinical Research Miscellaneous Commercial ServicesCommercial Services Part of CRA Holdings LLC, Chicago Center for Clinical Research is an American company that provides clinical research services. The company was founded by Michael H. Davidson. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Preventive Cardiology Institute, Inc. | Director/Board Member | ||
National Lipid Association
 National Lipid Association Miscellaneous Commercial ServicesCommercial Services The National Lipid Association aims to improve the practice of lipid management in clinical medicine. The non-profit company is based in Jacksonville, FL and has subsidiaries in the United States. The organization's mission is to enhance lipid management in clinical medicine, and its goals are consistent with this mission statement. | Miscellaneous Commercial Services | President | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
| INSEAD | College/University | Masters Business Admin | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Founder | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Chief Executive Officer | |
SonoThera, Inc.
 SonoThera, Inc. Pharmaceuticals: OtherHealth Technology SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation. | Pharmaceuticals: Other | Founder | |
Trofi Nutritionals, Inc.
 Trofi Nutritionals, Inc. Specialty StoresRetail Trade Trofi Nutritionals, Inc. is a private company located in the US that is focused on advancing personal health management through next-generation nutritional wellness solutions. The American company works with partners to translate functional compound discoveries into nutritional solutions. | Specialty Stores | Founder | |
NanoPhoria Srl
 NanoPhoria Srl Drugstore ChainsRetail Trade NanoPhoria Srl is an Italian company that operates as a non-viral drug delivery platform. The company is based in Milan, Italy. The company was founded by Daniele Catalucci, Michele Iafisco, Alessio Alogna, Claudio de Luca. Claudio de Luca has been the CEO since incorporation. | Drugstore Chains | Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
| The University of Chicago Department of Medicine | College/University | Corporate Officer/Principal | |
NewAmsterdam Pharma BV
 NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
Inositec AG
 Inositec AG Pharmaceuticals: MajorHealth Technology Inositec AG develops small molecules as alternatives to antibiotics. It also develops a non-antibiotic small molecule that neutralizes the toxins secreted by clostridium toxins. The company was founded by Mattias Ivarsson, Bastien Castagner and Jean-Christophe Leroux in December 2015 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
Jocasta Neuroscience, Inc.
 Jocasta Neuroscience, Inc. BiotechnologyHealth Technology Jocasta Neuroscience, Inc. provides biological products development services. The company is based in New Castle, DE. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 21 |
| Niederlande | 7 |
| Belgien | 7 |
| Frankreich | 6 |
| Vereinigtes Königreich | 5 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Retail Trade | 3 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 164 |
| Corporate Officer/Principal | 64 |
| Chairman | 58 |
| Independent Dir/Board Member | 46 |
| Chief Executive Officer | 46 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Edwin Moses | 35 |
| Bo Jesper Hansen | 34 |
| Catherine Moukheibir | 29 |
| Michael Davidson | 27 |
| David Solomon | 22 |
| Craig Tooman | 22 |
| Peter John Fellner | 21 |
| Peter Nordkild | 20 |
| Hilde Windels | 18 |
| Erik Schropp | 16 |
| Michel Lucien Pettigrew | 16 |
| Mark Rothera | 14 |
| Per Gunnar Falk | 12 |
| Antonius Berkien | 11 |
| Antonin Rollet de Fougerolles | 9 |
- Börse
- Insiders
- Jorgen Wittendorff
- Unternehmensverbindungen
